A Structural Switch between Agonist and Antagonist Bound Conformations for a Ligand-Optimized Model of the Human Aryl Hydrocarbon Receptor Ligand Binding Domain - Wikidata - awgldk - TriplyDB

A Structural Switch between Agonist and Antagonist Bound Conformations for a Ligand-Optimized Model of the Human Aryl Hydrocarbon Receptor Ligand Binding Domain

A Structural Switch between Agonist and Antagonist Bound Conformations for a Ligand-Optimized Model of the Human Aryl Hydrocarbon Receptor Ligand Binding Domain

http://www.wikidata.org/entity/Q34792371

about

Low-Dose Mixture Hypothesis of Carcinogenesis Workshop: Scientific Underpinnings and Research Recommendations Anti-androgen flutamide suppresses hepatocellular carcinoma cell proliferation via the aryl hydrocarbon receptor mediated induction of transforming growth factor-β1 Mechanistic Investigations Into the Developmental Toxicity of Nitrated and Heterocyclic PAHs Adaptation of the human aryl hydrocarbon receptor to sense microbiota-derived indoles.Ligand-Specific Transcriptional Mechanisms Underlie Aryl Hydrocarbon Receptor-Mediated Developmental Toxicity of Oxygenated PAHs.Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction Comparison of anti-inflammatory mechanisms of mango (Mangifera Indica L.) and pomegranate (Punica Granatum L.) in a preclinical model of colitis Conformational modulation of the farnesoid X receptor by prenylflavonoids: Insights from hydrogen deuterium exchange mass spectrometry (HDX-MS), fluorescence titration and molecular docking studies.Mechanisms and therapeutic prospects of polyphenols as modulators of the aryl hydrocarbon receptor.Role of the aryl hydrocarbon receptor in carcinogenesis and potential as an anti-cancer drug target.Activation helix orientation of the estrogen receptor is mediated by receptor dimerization: evidence from molecular dynamics simulations.Divergent Ah Receptor Ligand Selectivity during Hominin Evolution.Nuclear transport of the human aryl hydrocarbon receptor and subsequent gene induction relies on its residue histidine 291.TCDD, FICZ, and Other High Affinity AhR Ligands Dose-Dependently Determine the Fate of CD4+ T Cell Differentiation.Structure-Activity Relationships of the Main Bioactive Constituents of Euodia rutaecarpa on Aryl Hydrocarbon Receptor Activation and Associated Bile Acid Homeostasis.

P2860

Q26741639-A8F22EC7-BE60-4A1B-AAB6-79906AA1ED4F Q28260352-8E08C015-F35D-47C0-9F05-45B8C1ED7CA2 Q33632087-4266B006-2680-443D-AD61-3E026112E4DB Q35733882-833DC68F-AB47-4AA9-A74D-7D3281E17023 Q36181367-75FD8469-9D8E-4F4F-8159-CC083C207C68 Q36379436-A5B02681-7873-439B-B029-D22C56EC13FF Q37262589-57861068-428B-40AB-A88F-8DD55DFC67B1 Q38809529-8BA963B6-064F-4A5A-AFD5-F959889EB044 Q39176010-A06FC1E7-BAE8-4C6B-8DF7-153B983532AB Q39309007-FE444664-F23C-4675-B2A2-6925895C3984 Q40993997-35BEB8AA-51EB-455F-91AA-84D21053413D Q41653511-29D66FBE-99AC-4FE6-A94B-5E6A7E8B8830 Q47375338-69A60B9D-5336-41DD-A833-51A956018A01 Q50081147-E9DC3530-EF86-4825-B2D4-3F0B34757195 Q52691794-E6488D1C-60C5-4982-A400-488FC4C712AB

P2860

A Structural Switch between Agonist and Antagonist Bound Conformations for a Ligand-Optimized Model of the Human Aryl Hydrocarbon Receptor Ligand Binding Domain

http://www.wikidata.org/entity/Q34792371

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

A Structural Switch between Ag ...... Receptor Ligand Binding Domain

@ast

A Structural Switch between Ag ...... Receptor Ligand Binding Domain

@en

A Structural Switch between Ag ...... Receptor Ligand Binding Domain

@nl

type

label

A Structural Switch between Ag ...... Receptor Ligand Binding Domain

@ast

A Structural Switch between Ag ...... Receptor Ligand Binding Domain

@en

A Structural Switch between Ag ...... Receptor Ligand Binding Domain

@nl

prefLabel

A Structural Switch between Ag ...... Receptor Ligand Binding Domain

@ast

A Structural Switch between Ag ...... Receptor Ligand Binding Domain

@en

A Structural Switch between Ag ...... Receptor Ligand Binding Domain

@nl

P1433

Q34792371-5B054521-A645-4C0C-8789-FCFAB72429F9

P1476

Q34792371-0624324D-90A4-45ED-B06E-7638F5D36247

P2093

Q34792371-018D877E-D977-4CBA-94E0-8635BBE9F019

Q34792371-1486B9D5-7F93-4C71-A44E-86F66DD3A020

Q34792371-2115566E-BEFC-4E24-926C-DC371F828D0A

Q34792371-5247DD64-109F-479C-9484-9860F638A65F

Q34792371-7A4125AC-2E74-46FF-A8FC-A15CCD631F9F

Q34792371-9BFEFD42-4C01-4C49-A20C-B45DD670310F

Q34792371-C1063022-D4CC-4E11-AB46-E53156D6C8AA

P2860

Q34792371-0504D3CD-9194-4E77-A5B2-E6A7D4CF32DB

Q34792371-0EAF299C-180B-4DF4-AC21-91F8091BE177

Q34792371-1B7AA0DB-CDA9-4556-89B8-725E66E9BBCD

Q34792371-1F538725-DAD9-461C-8B2F-98233CFC7435

Q34792371-2141CCE8-231A-4F39-8463-66F2ECA8FACC

Q34792371-2C8CDBD2-5BD5-4DA6-A41A-5E0D2034D3AA

Q34792371-2E70ADEB-ECA8-4267-B320-3B80473ACC40

Q34792371-38B31616-204D-4911-8FC3-39CD8B8706E4

Q34792371-3FC355AB-ED6E-4324-8C5F-766C2F9B74B1

Q34792371-45E833BD-DEDC-43E5-99F4-C1A10F1EF83B

P304

Q34792371-5823C037-3F90-4BCF-886D-871487215C32

P31

Q34792371-6B3F8EDF-089B-4205-B040-45688CD5873C

P356

Q34792371-16726030-CD06-416A-94C3-089A48740F3E

P433

Q34792371-D756996B-09B4-4843-811F-DEB0F004BCFF

P478

Q34792371-A3961583-0392-48B4-BE6F-8AD29858024F

P577

Q34792371-C255BE16-3C54-4506-803F-C4A29EB8E573

P5875

Q34792371-576F8D38-9E62-460C-8883-8091444C76FC

P698

Q34792371-E385FE36-B5BA-4659-9FC0-B1E46C4F449C

P921

Q34792371-3FB9673E-1BAA-42EE-B015-6941C66940DA

P932

Q34792371-FC2324C5-E86A-40DC-9224-EE82A76D6DE0

P356

P1433

P1476

A Structural Switch between Ag ...... Receptor Ligand Binding Domain

@en

P2093

Arden Perkins

http://www.w3.org/2001/XMLSchema#string

Gary H Perdew

http://www.w3.org/2001/XMLSchema#string

Jessica L Phillips

http://www.w3.org/2001/XMLSchema#string

Nancy I Kerkvliet

http://www.w3.org/2001/XMLSchema#string

Robert L Tanguay

http://www.w3.org/2001/XMLSchema#string

Siva K Kolluri

http://www.w3.org/2001/XMLSchema#string

William H Bisson

http://www.w3.org/2001/XMLSchema#string

P2860

Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells

Diversity and modularity of G protein-coupled receptor structures

Structure of a flavin-binding plant photoreceptor domain: Insights into light-mediated signal transduction

Structural basis for PAS domain heterodimerization in the basic helix-loop-helix-PAS transcription factor hypoxia-inducible factor

Artificial ligand binding within the HIF2 PAS-B domain of the HIF2 transcription factor

Principles of Ligand Binding within a Completely Buried Cavity in HIF2α PAS-B

VMD: visual molecular dynamics

The aryl hydrocarbon receptor complex and the control of gene expression

The anti-inflammatory drug leflunomide is an agonist of the aryl hydrocarbon receptor

Effects of aryl hydrocarbon receptor null mutation and in utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on prostate and seminal vesicle development in C57BL/6 mice

P304

645-669

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/BIOLOGY3040645

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267102258

http://www.w3.org/2001/XMLSchema#string

P698

25329374

http://www.w3.org/2001/XMLSchema#string

P921

P932

4280506

http://www.w3.org/2001/XMLSchema#string